Novel qcrb inhibitors for the treatment of tuberculosis
Ended Project Grant Awarded Last action
- Award ID
- R41AI145514
- Recipient
-
Lgenia Inc. UEI JFZLTK7QH945
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- -$225,343
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Place of performance
- Indiana, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$225,343 | |
| Amendment | -$225,343 | |
| Original award | $225,343 |
Quick answers
Who received award R41AI145514?
R41AI145514 was awarded to Lgenia Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 1, 2020.
How much is award R41AI145514 worth?
Obligations on R41AI145514 net to -$225,343: more has been deobligated than obligated.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award